Arkstone Introduces Interpretations of Skin Scrapings and Epidermal Samples
New Innovation Advances Topical Antibiotic Treatment for Superficial Infections
Arkstone Medical Solutions, the leading provider of laboratory infectious disease reporting and proactive antimicrobial stewardship, continues to spearhead innovation in infectious disease analysis. OneChoice, the cutting-edge system developed by Arkstone to provide physicians with patient-specific treatment recommendations, now includes interpretations of laboratory data taken via skin scrapings and epidermal samples. This advancement revolutionizes the management of superficial infections with a focus on topical antibiotic treatment.Addressing Superficial Infections with Targeted Topical AntibioticsArkstone recognizes the critical need for precise and personalized care when addressing superficial infections, such as fungal infections and other skin conditions. By integrating data analysis from skin scrapings and epidermal samples into the OneChoice platform, Arkstone will provide healthcare providers with unparalleled insights into each patient's condition. This enables them to make informed decisions regarding the most effective topical antibiotic treatments while minimizing systemic exposure to medications, thereby optimizing patient care and upholding antimicrobial stewardship principles.Precision-Guided Patient Care: A Personalized ApproachArkstone is dedicated to taking personalization in patient care to new heights. The latest innovation in interpreting skin scrapings and epidermal samples adds another layer of precision to the OneChoice reports. This new data analysis is incorporated into the proprietary decision engine, which leverages advanced artificial intelligence and deep insights into infectious diseases. By considering individual patient characteristics, including age, gender, diagnosis, and allergy profiles, healthcare providers can receive tailored recommendations that align with each patient's unique needs. The focus on topical antibiotics emphasizes a more targeted approach to managing superficial infections effectively."We are thrilled to extend our OneChoice platform to include data interpretations from skin scrapings and epidermal samples," says Dr. Ari Frenkel, infectious disease specialist, and Co-Founder & Chief Science Officer of Arkstone. "This innovation marks a significant advancement in precision-guided medicine, enabling healthcare providers to deliver targeted topical antibiotic treatments for superficial infections while adhering to antimicrobial stewardship principles."
News
Latest Insights and Updates
Stay informed with our featured press releases.
Arkstone’s AI Clinical Decision Support Helps Treat Over 1 Million Patients
The Arkstone platform has been used by doctors across the USA to diagnose and treat diseases in over 1 million patients, a major milestone reached in October 2025. The milestone underscores Arkstone’s leadership in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical guidance and its expanding partnerships across the U.S. and around the world.
Arkstone Announces RightDose, a Groundbreaking Enhancement to Ensure Proper Antimicrobial Prescribing
This innovative feature addresses the complexities healthcare providers face when dosing for different age groups and accommodating reduced renal and hepatic function
Arkstone Medical Solutions Launches Breakthrough OneChoice Report for Microbiology Lab Results
Leading Provider of Laboratory Infectious Disease Reporting Expands Precision-Guided Treatment Recommendations to Cultures and Stains
Customer Testimonials
Arkstone's solutions have transformed our patient care.
"Clinically, Arkstone has significantly decreased my time until optimal treatment. Thanks for your help saving limbs!"
"Successful wound healing requires expertise in the management of bioburdens, biofilms, and microbes. Arkstone's advanced input and patient-specific recommendations have translated to superior results in wound healing and patient satisfaction. This has led to better outcomes, unparalleled medical decision making, and respect among medical professionals in the mid-south."
"Our providers are so happy we partnered with Arkstone as now they have in depth and actionable guidance with each lab result."
"The Arkstone Reports provide recommendations and infection control measures that have significantly improved the way we care for patients. It is truly a unique feature that will revamp our antimicrobial stewardship programs."
"Arkstone does a great job of identifying pathogens and resistance to certain antibiotics, and we love the fact that the reports use a score to rank treatments that doctors can consider. The Arkstone Report assists our physicians in making wise decisions for antibiotic use and patient care."
"When it comes to PCR, results can be complicated. Arkstone is a great clinical tool that can help physicians choose the right regimen for their patients."
"After following the Arkstone antibiotic treatment recommendation my patient's wound is healing, the small red area is gone, and the overall redness has decreased indicating the infection is gone."
Take the Next Step, Try OneChoice®
No more guesswork. No more lookup tools. No more inaccuracies and inconsistencies. No more stopping to ask for directions.
